Skip to main content
. 2021 Jul 28;9(1):10.1128/spectrum.00638-21. doi: 10.1128/spectrum.00638-21

TABLE 2.

Values for continuous clinical parameters and results of Wilcoxon rank-sum test comparing foals of vaccinated mares (n = 14) with control foals (n = 8)

Clinical or hematological parameter Median (range) for:
P valuea
Vaccinees Controls
Frequencyb of:
    Tachypneac 51.5 (36 to 108) 60.5 (37 to 80) 0.1825
    Temp >103°F 6 (0 to 50) 8.5 (4 to 20) 0.3362
    Temp >102.5°F 12.5 (1 to 61) 14 (8 to 28) 0.5379
    Coughing 5 (0 to 23) 9.5 (2 to 18) 0.1074
Frequency (wks) of WBC >13,000 cells/μl 2 (0 to 7) 1.5 (0 to 5) 0.6959
Maximum WBC (1,000 cells/μl) 22.34 (11.67 to 71.74) 15.72 (12.27 to 32.35) 0.7135
Frequency (wks) of fibrinogen >400 mg/dl 3.5 (1 to 9) 3 (1 to 5) 0.3848
Maximum fibrinogen (mg/dl) 800 (400 to 1,200) 600 (400 to 1,100) 0.3862
Duration (wks) of ultrasound lesions 3 (1 to 8) 3 (2 to 4) 0.9717
Maximum diam of lesions (mm) 116.25 (13.0 to 342.0) 138.0 (32.5 to 212.2) 0.9203
Sum of diam of lesions (mm) 201.3 (13.0 to 1,807.4) 194.3 (72.5 to 549.1) 0.8154
No. of days treated
    All foals 12.5 (0 to 85) 17 (0 to 24) 0.4472
    Pneumonic foals 15 (11 to 85) 19 (8 to 24) 0.9152
a

Derived by Wilcoxon rank-sum test.

b

Frequency of observation was twice daily; 2 observations = 1 day.

c

Defined as a respiratory rate of >40 breaths/min.